The 16th European Glaucoma Society Congress convenes in Dublin

News
Article

This year’s meeting will take place in Ireland’s technology and business hub

A view of the Convention Centre Dublin from the River Liffey. Image credit: ©Alexander – stock.adobe.com

The venue is located in Dublin’s Docklands, a neighborhood noted for its connections to technology companies and finance firms. Image credit: ©Alexander – stock.adobe.com

From 1 June to 4 June, the European Glaucoma Society (EGS) will convene in Dublin, Ireland, for the 16th EGS Congress. The four-day meeting will include lectures, panels and demonstrations on a number of surgical, practice-centric and patient-focused topics. The first day of programming will include a keynote lecture titled “Interpreting surgical innovations,” presented by Professor Roger Kneebone, MD, PhD.

Hands-on surgical symposia, taking place each day, will focus on bleb forming devices, trabeculectomy, tubes and MIGS. Posters at the meeting are divided into a wide range of categories: diagnosis, surgical, laser and medical treatments, follow up and glaucoma progression, genetic research,pathogenesis, epidemiology, quality of life, health economics and visual disability. A Technical Exhibition will feature industry partners showcasing new products and devices.

In a welcome letter, the EGS leadership and programme planning committee announced1 the popular EGS Surgery Day would return for 2024, putting a focus on challenges related to novel and innovative surgical techniques. The letter also highlighted recent efforts which would be spotlighted at the congress. Over the last few years, leadership wrote, the society has intensively worked on “the Real World Data Project, the Surgery Project, the EGS Glaucoma Fellowship Project, the Research Priorities Project, the Patients Initiative and the Outcomes Project.” Innovations and updates from those ongoing projects will be incorporated into the meeting’s scientific programme. These core concepts “[are] building the scaffold for a high quality scientific exchange from the first day until the very last session in an open-minded, multicultural environment,” the letter read.

The venue for this year’s meeting is The Convention Centre Dublin (The CCD), located in Dublin’s Docklands, a neighborhood noted for its connections to technology companies and finance firms.

General information about the Congress can be found at this link. The full scientific programme, including abstract book and the programme-at-a-glance, can be found at this link.

Reference

  1. European Glaucoma Society Executives. Welcome letter. European Glaucoma Society. Published May 2024. Accessed May 2024. https://egscongress.org/welcome/

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
© 2025 MJH Life Sciences

All rights reserved.